Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome

Scandinavian Journal of Rheumatology

Volumn 32, Issue 6, 2003, Pages 337-342

  Nissinen, R ^a   Paimela, L ^b   Julkunen, H ^c   Tienari, P J ^d   Leirisalo Repo, M ^e   Palosuo, T ^a   Vaarala, O ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b ORTON Invalid Foundation   (Finland)

^c PEIJAS HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Autoimmunity; Citrulline; Filaggrin; Peptidylarginine deiminase; Rheumatoid arthritis

Indexed keywords

ANTIGEN; ARGININE; CITRULLINE; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN G ANTIBODY; PROTEIN ARGININE DEIMINASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; MEASUREMENT; MULTIPLE SCLEROSIS; PATIENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN MODIFICATION; RHEUMATOID ARTHRITIS; SERUM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CITRULLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROLASES; INTERMEDIATE FILAMENT PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME;

EID: 0842287339     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740410004990     Document Type: Article

References (36)

1. Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999;162:585-94.
2. Nagata S, Yamagiwa M, Inoue K, Senshu T. Estrogen regulates peptidylarginine deiminase levels in a rat pituitary cell line in culture. J Cell Physiol 1990;145:333-9.
3. Takahara H, Kusubata M, Tsuchida M, Kohsaka T, Tagami S, Sugawara K. Expression of peptidylarginine deiminase in the uterine epithelial cells of mouse is dependent on estrogen. J Biol Chem 1992;267:520-5.
4. Utz PJ, Gensler TJ, Anderson P. Death, autoantigen modifications, and tolerance. Arthritis Res 2000;2:101-14.
5. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101:273-81.
6. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA. Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford) 2002;41:809-14.
7. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000;43:155-63.
8. Vincent C, Nogueira L, Sebbag M, Chapuy-Regaud S, Arnaud M, Letourneur O, et al. Detection of antibodies to deiminated recombinant rat filaggrin by enzyme-linked immunosorbent assay: a highly effective test for the diagnosis of rheumatoid arthritis. Arthritis Rheum 2002;46:2051-8.
9. Aho K, Palosuo T, Heliovaara M, Knekt P, Alha P, von Essen R. Antifilaggrin antibodies within 'normal' range predict rheumatoid arthritis in a linear fashion. J Rheumatol 2000;27:2743-6.
10. Guerrin M, Ishigami A, Mechin MC, Nachat R, Valmary S, Sebbag M, et al. cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. Biochem J 2003;370:167-74.
11. Rus'd AA, Ikejiri Y, Ono H, Yonekawa T, Shiraiwa M, Kawada A, et al. Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. Eur J Biochem 1999;259(3):660-9.
12. Terakawa H, Takahara H, Sugawara K. Three types of mouse peptidylarginine deiminase: characterization and tissue distribution. J Biochem (Tokyo) 1991;110:661-6.
13. Sugawara K, Oikawa Y, Ouchi T. Identification and properties of peptidylarginine deiminase from rabbit skeletal muscle. J Biochem (Tokyo) 1982;91(3):1065-71.
14. Asaga H, Nakashima K, Senshu T, Ishigami A, Yamada M. Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils. J Leukoc Biol 2001;70:46-51.
15. Ishigami A, Kuramoto M, Yamada M, Watanabe K, Senshu T. Molecular cloning of two novel types of peptidylarginine deiminase cDNAs from retinoic acid-treated culture of a newborn rat keratinocyte cell line. FEBS Lett 1998;433:113-8.
16. Yamakoshi A, Ono H, Nishijyo T, Shiraiwa M, Takahara H. Cloning of cDNA encoding a novel isoform (type IV) of peptidylarginine deiminase from rat epidermis. Biochim Biophys Acta 1998;1386:227-32.
17. Kubilus J, Baden HP. Purification and properties of a brain enzyme which deiminates proteins. Biochim Biophys Acta 1983;745:285-91.
18. Watanabe K, Senshu T. Isolation and characterization of cDNA clones encoding rat skeletal muscle peptidylarginine deiminase. J Biol Chem 1989;264:15255-60.
19. Arnett F, Edworthy S, Bloch D, McShane D, Fries J, Cooper N, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
20. Paimela L, Palosuo T, Leirisalo-Repo M, Helve T, Aho K. Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis. Br J Rheumatol 1995; 34:1146-50.
21. Palosuo T, Lukka M, Alenius H, Kalkkinen N, Aho K, Kurki P, et al. Purification of filaggrin from human epidermis and measurement of antifilaggrin autoantibodies in sera from patients with rheumatoid arthritis by an enzyme-linked immunosorbent assay. Int Arch Allergy Immunol 1998;115:294-302.
22. Paimela L, Palosuo T, Aho K, Lukka M, Kurki P, Leirisalo-Repo M, et al. Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis. Ann Rheum Dis 2001;60:32-5.
23. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
24. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
25. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13:227-31.
26. Tsuchida M, Takahara H, Minami N, Arai T, Kobayashi Y, Tsujimoto H, et al. cDNA nucleotide sequence and primary structure of mouse uterine peptidylarginine deiminase. Detection of a 3′-untranslated nucleotide sequence common to the mRNA of transiently expressed genes and rapid turnover of this enzyme's mRNA in the estrous cycle. Eur J Biochem 1993;215:677-85.
27. Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, et al. Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 1999;6:63-70.
28. Vossenaar E, van Mansum W, van der Heijden A, Nijenhuis S, van Boekel M, van Venrooij WJ. Expression of PAD enzymes and occurence of citrulline- containing proteins in human blood and synovial fluid cells. Arthritis Res 2002; 4(Suppl 1):24.
29. Moscarello MA, Wood DD, Ackerley C, Boulias C. Myelin in multiple sclerosis is developmentally immature. J Clin Invest 1994;94:146-54.
30. de Seze J, Dubucquoi S, Lefranc D, Virecoulon F, Nuez I, Dutoit V, et al. IgG reactivity against citrullinated myelin basic protein in multiple sclerosis. J Neuroimmunol 2001; 117:149-55.
31. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997;3:797-801.
32. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark A. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982;298:167-9.
33. Mariotti S, Anelli S, Ruf J, Bechi R, Czarnocka B, Lombardi A, et al. Comparison of serum thyroid microsomal and thyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab 1987;65:987-93.
34. Lee SS, Adu D, Thompson RA. Anti-myeloperoxidase antibodies in systemic vasculitis. Clin Exp Immunol 1990; 79:41-6.
35. Jones DE. Autoantigens in primary biliary cirrhosis. J Clin Pathol 2000;53:813-21.
36. Bjork E, Velloso LA, Kampe O, Karlsson FA. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994;43:161-5.